$13.31
0.403.06%
Last update: Oct 8, 5:20 PM
$13.35
0.443.37%
Iovance Biotherapeutics Inc
IOVANASDAQ
Iovance Biotherapeutics (IOVA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Iovance Biotherapeutics (IOVA) last issued guidance on September 29, 2026 for fiscal year 2026. The company guided revenue in the range of $410M - $420M for the period.
Compared to prior guidance, Iovance Biotherapeutics raised its revenue forecast from a prior range of $350M - $370M.
Iovance Biotherapeutics has issued 13 guidance updates between August 8, 2024 and September 29, 2026. During this period, the company raised its outlook 4 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.16 | $-0.19 | $-0.27 |
| Actual | $-0.11 | $-0.19 | $-0.18 | $-0.25 |
| Surprise | +21.4% | -18.8% | +5.26% | +7.41% |
| Revenue | ||||
| Estimate | $87.6M | $76.0M | $78.6M | $71.8M |
| Actual | $99.3M | $71.4M | $86.8M | $67.5M |
| Surprise | +13.4% | -5.96% | +10.3% | -6.08% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.09 | $-0.11 | $-0.09 |
| Revenue | ||||
| Consensus | $114.1M | $124.5M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.11 | $-0.14 | 21.4 % |
| Q1 | May 7, 2026 | $-0.19 | $-0.16 | -18.8 % |
| Q4 | Feb 24, 2026 | $-0.18 | $-0.19 | 5.26 % |
| Q3 | Nov 6, 2025 | $-0.25 | $-0.27 | 7.41 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $99.31M | $87.60M | 13.4 % |
| Q1 | May 7, 2026 | $71.43M | $75.95M | -5.96 % |
| Q4 | Feb 24, 2026 | $86.77M | $78.64M | 10.3 % |
| Q3 | Nov 6, 2025 | $67.46M | $71.82M | -6.08 % |
